Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mesothelioma is an aggressive cancer, for which no curative oncological treatment currently exists. This article outlines the options for managing malignant pleural effusions, describes the developments in chemotherapy over the past 10 years and summarizes the evidence for prophylactic and palliative radiotherapy.

Original publication

DOI

10.12968/hmed.2015.76.7.384

Type

Conference paper

Publication Date

07/2015

Volume

76

Pages

384 - 389

Keywords

Antineoplastic Agents, Catheters, Indwelling, Chest Tubes, Folic Acid Antagonists, Humans, Lung Neoplasms, Mesothelioma, Pleural Effusion, Malignant